Us Regulator Approves Pill Form Of Wegovy Weight-loss Drug

The US Food and Drug Administration (FDA) has approved a pill type of nan weight-loss supplier Wegovy, according to pharmaceutical elephantine Novo Nordisk.

It is nan first pill of its benignant to person support from nan regulator, marking a caller era for weight-loss drugs.

Wegovy's Danish makers Novo Nordisk said nan once-daily pill was a "convenient option" to nan injectable and would supply nan aforesaid weight nonaccomplishment arsenic nan shot. It comes aft Wegovy was approved by nan FDA specifically for weight loss.

Others for illustration Ozempic, which has akin weight-loss effects, were chiefly approved for nan curen of Type 2 diabetes.

The BBC has contacted nan FDA for comment.

The Wegovy pill showed an mean weight nonaccomplishment of 16.6% during Novo Nordisk's trials, the patient said connected Monday.

A 3rd of astir 1,300 participants knowledgeable 20% aliases greater weight nonaccomplishment successful nan aforesaid trial, it added.

The pill is expected to beryllium launched successful nan US successful early January 2026.

"Patients will person a convenient, once-daily pill that tin thief them suffer arsenic overmuch weight arsenic nan original Wegovy injection," said Mike Doustdar, nan firm's main executive.

The pill type of Wegovy could springiness Novo Nordisk's income a boost aft a challenging twelvemonth which saw its shares descent arsenic it warned complete its profits.

The institution has faced aggravated title successful nan weight-loss marketplace from rival drugmakers for illustration Eli Lilly.

Novo Nordisk's shares roseate by almost 10% successful after-hours waste and acquisition successful New York aft nan announcement.